"Somos Clínica do Coração, mas cuidamos de todo o seu corpo ♥️"

During the past decade, Centro de Pesquisa Clínica do Coração conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 1 clinical trials were completed, i.e. on average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 1 clinical trials were completed. i.e. 8.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro de Pesquisa Clínica do Coração" #1 sponsor was "Hospital Israelita Albert Einstein" with 5 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Bayer" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Saint Luke's Health System" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Pesquisa Clínica do Coração" #1 collaborator was "CytoDyn, Inc." with 2 trials as a collaborator, "Ministry of Health, Brazil" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Colorado Prevention Center" with 1 trials as a collaborator and "George Clinical Pty Ltd" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Centro de Pesquisa Clínica do Coração" are "Acute Coronary Syndrome" (2 trials), "COVID-19 Pneumonia" (2 trials), "Heart Failure" (2 trials), "Heart Failure With Preserved Ejection Fraction" (2 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Centro de Pesquisa Clínica do Coração" in a lesser frequency.

Most popular intervention types in "Centro de Pesquisa Clínica do Coração" are "Drug" (11 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Leronlimab" (2 trials), "Antiplatelet Monotherapy" (1 trials), "Apixaban" (1 trials) and "Apixaban matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Pesquisa Clínica do Coração" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Centro de Pesquisa Clínica do Coração". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centro de Pesquisa Clínica do Coração, 2 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Pesquisa Clínica do Coração, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".